3rd Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$380,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Unified Framework for Fixing Our Broken Tax Code; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Government Accountability Office (GAO); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); White House Office; Natl Economic Council (NEC); Agriculture, Dept of (USDA); Treasury, Dept of; Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 631 (115th), S. 205 (115th)

Animals ANI

Issues related to compounded pharmaceuticals for animals; H.R. 623, FairnesstoPetOwnersActof 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); White House Office; Government Accountability Office (GAO); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Personnel Management (OPM); SENATE; Agriculture, Dept of (USDA); Food & Drug Administration (FDA)

Bills named: H.R. 623 (115th)

Defense DEF

Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Office of Personnel Management (OPM); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Natl Drug Control Policy (NDCP); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: S. 1519 (115th), H.R. 2810 (115th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Defense, Dept of (DOD); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Economic Council (NEC); White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Government Accountability Office (GAO); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Treasury, Dept of; Office of Natl Drug Control Policy (NDCP); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1628 (115th), H.R. 2430 (115th), S. 934 (115th)

Alcohol and Drug Abuse ALC

Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Treasury, Dept of; Health Resources & Services Administration (HRSA); White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Government Accountability Office (GAO); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Natl Economic Council (NEC); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 3545 (115th), S. 581 (115th), H.R. 1271 (115th), S. 523 (115th), H.R. 3528 (115th), H.R. 1854 (115th), S. 778 (115th), S. 1850 (115th), H.R. 1375 (115th)

Health Issues HCR

S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Government Accountability Office (GAO); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Treasury, Dept of; White House Office; Health Resources & Services Administration (HRSA); Natl Economic Council (NEC); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 469 (115th), H.R. 1245 (115th), S. 41 (115th), H.R. 1776 (115th), H.R. 242 (115th), S. 771 (115th), S. 222 (115th)

Medicare/Medicaid MMM

H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); Defense, Dept of (DOD); White House Office; Health & Human Services, Dept of (HHS); SENATE; Medicare Payment Advisory Commission (MedPAC); Treasury, Dept of; Office of Management & Budget (OMB); Natl Economic Council (NEC); Food & Drug Administration (FDA)

Bills named: H.R. 3271 (115th), S. 109 (115th), S. 870 (115th), S. 637 (115th), S. 413 (115th), H.R. 1939 (115th), H.R. 1316 (115th), H.R. 3921 (115th), H.R. 592 (115th), H.R. 394 (115th), H.R. 1038 (115th)

Pharmacy PHA

Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —
MICHAEL TOMBERLIN —

Contacted: Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); White House Office; Agriculture, Dept of (USDA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE; Office of Personnel Management (OPM)

Bills named: H.R. 749 (115th), H.R. 421 (115th), H.R. 2871 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.